IL Pharmaceuticals

Mediwound Ltd (MDWD)

Track

Track

Mediwound Ltd experienced net insider selling totaling approximately $75,447 over the past ninety days. Executives drove this activity, primarily through multiple divestments following the August earnings report. While the stock price declined seven percent during this period, these transactions reflect recent leadership adjustments rather than broader market sentiment regarding future performance.
Ticker: MDWD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Mediwound Ltd. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
Rubinstein Samuel Non-Executive Director
Transaction date
Purchase
Price
71.95
Quantity 24,798 -31.0%
Value US$3,210,589
2.5
Rubinstein Samuel Non-Executive Director
Transaction date
Sale
Price
282.89
Quantity 42,416 -11.4%
Value US$2,889,026
Hess Shmuel COO & Chief Commercial Officer Officer
Transaction date
Sale
Price
53.42
Quantity 98,869 -16.3%
Value US$602,203
Hess Shmuel COO & Chief Commercial Officer Officer
Transaction date
Sale
Price
12.72
Quantity 1,979 -100.0%
Value US$25,173
Shmulik Hess Officer Officer
Transaction date
Proposed sale
Price
12.70
Quantity 3,958
Value US$50,267
Hess Shmuel COO & Chief Commercial Officer Officer
Transaction date
Sale
Price
13.00
Quantity 1,865 -100.0%
Value US$24,245
1.6
SHAMIR NACHUM Non-Executive Director
Transaction date
Purchase
Price
14.00
Quantity 5,825 +11.7%
Value US$81,550
1.6
SHAMIR NACHUM Non-Executive Director
Transaction date
Purchase
Price
13.98
Quantity 175 +0.4%
Value US$2,446
1.6
Fox David Morton Non-Executive Director
Transaction date
Purchase
Price
14.00
Quantity 1,797 +8.8%
Value US$25,149
1.6
Fox David Morton Non-Executive Director
Transaction date
Purchase
Price
14.23
Quantity 10 +0.0%
Value US$142
1.6
Fox David Morton Non-Executive Director
Transaction date
Purchase
Price
14.23
Quantity 1,730 +9.2%
Value US$24,609
2.5
Rubinstein Samuel Non-Executive Director
Transaction date
Purchase
Price
14.33
Quantity 150 +5.3%
Value US$2,150
Hess Shmuel Officer Officer
Transaction date
Proposed sale
Price
17.21
Quantity 3,693
Value US$63,557
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-02 2026-09-01 B Purchase
2.5
Rubinstein Samuel
Non-Executive Director
24,798 -31.0%
71.95
US$3,210,589 		24,798 -31.0% 71.95 US$3,210,589
2026-09-02 2026-09-01 S Sale
2.5
Rubinstein Samuel
Non-Executive Director
42,416 -11.4%
282.89
US$2,889,026 		42,416 -11.4% 282.89 US$2,889,026
2026-08-28 2026-08-27 S Sale
Hess Shmuel

COO & Chief Commercial Officer

Officer
98,869 -16.3%
53.42
US$602,203 		98,869 -16.3% 53.42 US$602,203
2026-08-28 2026-08-27 S Sale
Hess Shmuel

COO & Chief Commercial Officer

Officer
1,979 -100.0%
12.72
US$25,173 		1,979 -100.0% 12.72 US$25,173
2026-08-28 2026-08-27 PrS Proposed sale
Shmulik Hess

Officer

Officer
3,958
12.70
US$50,267 		3,958 12.70 US$50,267
2026-08-28 2026-08-26 S Sale
Hess Shmuel

COO & Chief Commercial Officer

Officer
1,865 -100.0%
13.00
US$24,245 		1,865 -100.0% 13.00 US$24,245
2026-06-04 2026-06-03 B Purchase
1.6
SHAMIR NACHUM
Non-Executive Director
5,825 +11.7%
14.00
US$81,550 		5,825 +11.7% 14.00 US$81,550
2026-06-04 2026-06-03 B Purchase
1.6
SHAMIR NACHUM
Non-Executive Director
175 +0.4%
13.98
US$2,446 		175 +0.4% 13.98 US$2,446
2026-06-02 2026-06-01 B Purchase
1.6
Fox David Morton
Non-Executive Director
1,797 +8.8%
14.00
US$25,149 		1,797 +8.8% 14.00 US$25,149
2026-06-02 2026-06-01 B Purchase
1.6
Fox David Morton
Non-Executive Director
10 +0.0%
14.23
US$142 		10 +0.0% 14.23 US$142
2026-06-02 2026-06-01 B Purchase
1.6
Fox David Morton
Non-Executive Director
1,730 +9.2%
14.23
US$24,609 		1,730 +9.2% 14.23 US$24,609
2026-06-01 2026-05-29 B Purchase
2.5
Rubinstein Samuel
Non-Executive Director
150 +5.3%
14.33
US$2,150 		150 +5.3% 14.33 US$2,150
2025-12-03 2025-12-02 PrS Proposed sale
Hess Shmuel

Officer

Officer
3,693
17.21
US$63,557 		3,693 17.21 US$63,557
Explore more

More insider trading research around Mediwound Ltd

More insider trades in IL
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity